Disease modifying therapies in multiple sclerosis: cost-effectiveness systematic review
Objective: To identify and describe cost-effectiveness studies that evaluate disease modifying therapies in the context of relapsing- remitting multiple sclerosis. Method: A systematic review of the literature was carried out by searching MEDLINE, Embase, the Cochrane Library, LILACS, the Tufts Medi...
Saved in:
Main Authors: | Cristian Eduardo Navarro (Author), Eliana Ordóñez-Callamand (Author), Juan Pablo Alzate (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis
by: Mehdi Rezaee, et al.
Published: (2024) -
Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
by: Chi-Yan Lee, et al.
Published: (2024) -
Disease Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
by: Negar Molazadeh, et al.
Published: (2023) -
Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis
by: Burks J, et al.
Published: (2017) -
Multiple Sclerosis and the Comparative Value Disease Modifying Therapy Report of the Institute for Clinical and Economic Review (ICER)
by: Paul C Langley
Published: (2017)